« All Events
Clarivate & Fierce Medtech: Medical Technologies to Watch 2024
May 8 @ 10:00 am - 11:00 am
Emerging medical technologies poised to transform patient care
The Clarivate Medical Technologies to Watch webinar spotlights medical technologies poised to deliver transformative advances in standards of care and realize better patient outcomes.
The landscape of medical device technologies is rapidly evolving, driven by innovation, research, and the pressing need to enhance patient care. In this webinar, Clarivate analysts identify key areas of medical device and diagnostics innovation to watch in the near-to-medium term. These technologies have significant potential for commercial as well as clinical success, benefiting medtech company bottom lines as well as advancing the cause of human health.
REGISTER»
This webinar will answer questions such as:
- What are the standout emerging medical technologies?
- How will these devices impact the market?
- What gaps in treatment do these devices fill?
- What hurdles will devices face in terms of adoption?
- What trends in technology do we see shaping the future of medtech?
Chris O’Hara has spent over 20 years in the medical device industry, with experience leading large commercial teams, developing strategy and fitting technology to patient care. His experience ranges from large strategics like Ethicon, Intuitive and Globus to start ups like Outset and now Virtual Incision. He has been working specifically in the robotics space for the past 14 years and has led teams that have launched 3 FDA approved robots in Soft Tissue and Spine/Ortho at Intuitive, Globus and Virtual Incision.
Director of Product Operations, Medtech Insights
Sean Messenger has cultivated more than a decade of experience working with the world’s top medical device firms to use data, analytics, and insights to solve their problems. Sean’s experience includes developing and executing product strategy for healthcare data and analytics solutions, directing operations and customer engagement to deliver large-scale market intelligence projects, and leading a global team of analysts responsible for monitoring, analyzing, and reporting on medical device trends.
Director, Medtech Insights
April Chan-Tsui leads a team of subject-matter experts providing data and insights for over 80 medical device markets across more than 50 countries globally. Since joining the team in 2006, April has held several roles within Medtech Insights, developing strong knowledge of numerous medtech markets across a vast range of therapy areas.
Matthew Arnold serves as a research analyst and content strategist. He joined Clarivate after covering the life science industries as a journalist for more than a decade and has followed pharmas and medtechs from the dawn of DTC advertising and mass-market blockbusters to the age of genetic medicine and surgical robotics.
Annette Boyle is the editor of BioWorld MedTech. She has covered biotech and the business of medicine for more than 15 years, providing in-depth reports and daily coverage for a range of U.S.-based B2B publications. At BioWorld, she offers insight into clinical trials, new product releases, the medical technology industry and other topics in women’s health, diabetes, cardiology, bioelectronic medicine, oncology, orthopedics and other segments. Annette holds a bachelor’s degree in political science from Amherst College and an MBA from the Yale School of Management.
